New Breast Cancer Drug Hits the Market - KCBD NewsChannel 11 Lubbock

3/3/08

New Breast Cancer Drug Hits the Market

Posted:

A new breast cancer drug has gained approval from the FDA but there is some criticism from others. Avastin is used with chemotherapy in late stage breast cancer patients to stop the growth of tumors. Genentech, the maker of the drug, says it gives patients more time.

Dr. David Schenkein of Genentech says, "It extends the amount of time a woman is alive without her disease progressing from 5.5 months to over 11 months."

But Avastin is controversial and expensive.  Critics argue that the drug doesn't improve life but only prolongs it.  It costs around $7,000 dollars each month.  Genentech says it will establish a cap- offering the drug for free after a patient has spent $55,000.

Powered by WorldNow

5600 Avenue A
Lubbock, TX. 79404

FCC Public File
publicfile@kcbd.com
806-744-1414
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KCBD. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.